Jennifer E Axilbund
Affiliation: Johns Hopkins University
- Genetic testing by cancer site: pancreasJennifer E Axilbund
Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Cancer J 18:350-4. 2012..Such high-risk individuals may benefit from increased surveillance, and strategies for early detection of pancreatic cancer are under evaluation...
- Patient perspective on the value of genetic counselling for familial pancreas cancerJennifer E Axilbund
Department of Oncology, School of Medicine, The Johns Hopkins University, Baltimore, Maryland, USA
Hered Cancer Clin Pract 3:115-22. 2005..To assess patient views regarding the value of genetic counselling for familial pancreas cancer in the absence of predictive genetic testing...
- Serrated polyposis: rapid and relentless development of colorectal neoplasiaDaniel L Edelstein
Department of Medicine, The Johns Hopkins University School of Medicine, 1830 East Monument Street, Baltimore, MD 21205, USA
Gut 62:404-8. 2013..Although associated with colorectal cancer, the course of SP is not well described...
- Familial pancreatic cancer: from genes to improved patient careRalph H Hruban
Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Hospital, Weinberg Building 2242, 401 North Broadway, Baltimore, MD 21231, USA
Expert Rev Gastroenterol Hepatol 1:81-8. 2007..This review focuses on the genetic basis for the familial aggregation of pancreatic cancer, with emphasis placed on the implications of the genetic alterations on clinical patient care...
- Absence of germline BRCA1 mutations in familial pancreatic cancer patientsJennifer E Axilbund
Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, Maryland, USA
Cancer Biol Ther 8:131-5. 2009....
- Risk of Colorectal and Other Cancers in Patients With Serrated PolyposisDaniel L Edelstein
Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland
Clin Gastroenterol Hepatol 13:1697-9. 2015..The risk of extracolonic cancer also appears to be increased, but this requires further evaluation. ..
- Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approachMarcia Irene Canto
Department of Medicine Gastroenterology, Johns Hopkins Medical Institution, Baltimore, MD 21205, USA
Clin Gastroenterol Hepatol 2:606-21. 2004..We prospectively evaluated the feasibility of screening for pancreatic neoplasia in high-risk individuals...
- Patient preferences regarding recontact by cancer genetics cliniciansConstance A Griffin
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA
Fam Cancer 6:265-73. 2007..Limited information exists on patient preferences concerning recontact to provide updated information. We evaluated colon cancer genetics patient preferences concerning recontact about advances in medical genetics...
- Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancerFrancis M Giardiello
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Am J Gastroenterol 109:1159-79. 2014..A detailed explanation of Lynch syndrome and the methodology utilized to derive these guidelines, as well as an explanation of, and supporting literature for, these guidelines are provided. ..
- A new phenotypic manifestation of familial adenomatous polyposisDaniel L Edelstein
Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Fam Cancer 10:309-13. 2011..002. No significant difference was noted in OMR between the two patient groups and controls. OMVD is a new phenotypic manifestation in patients with FAP and also may identify those with multiple adenomas without known gene mutation...